Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alban Canali

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|February 24, 2024
Minimal Residual Disease in Acute Myeloid Leukemia: Old and New ConceptsMathias Chea, Lucie Rigolot, Alban Canali, et al.
Cytometry. Part B, Clinical Cytometry|August 4, 2023
Use of a hybrid intelligence decision tree to identify mature B-cell neoplasmsInès Vergnolle, Theo Ceccomarini, Alban Canali, et al.
Ejhaem|March 9, 2026
Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic LeukaemiaLaetitia Largeaud, Charlotte Syrykh, Julie Vial, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2022
Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid LeukemiaAlban Canali, Inès Vergnolle, Sarah Bertoli, et al.
Leukemia|April 4, 2024
Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasmsCharles Dussiau, Thibault Comont, Camille Knosp, et al.
Blood Cancer Journal|May 31, 2024
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry studyCamille Gondran, Pierre-Yves Dumas, Emilie Bérard, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|February 24, 2024
Minimal Residual Disease in Acute Myeloid Leukemia: Old and New ConceptsMathias Chea, Lucie Rigolot, Alban Canali, et al.
Cytometry. Part B, Clinical Cytometry|August 4, 2023
Use of a hybrid intelligence decision tree to identify mature B-cell neoplasmsInès Vergnolle, Theo Ceccomarini, Alban Canali, et al.
Ejhaem|March 9, 2026
Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic LeukaemiaLaetitia Largeaud, Charlotte Syrykh, Julie Vial, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2022
Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid LeukemiaAlban Canali, Inès Vergnolle, Sarah Bertoli, et al.
Leukemia|April 4, 2024
Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasmsCharles Dussiau, Thibault Comont, Camille Knosp, et al.
Blood Cancer Journal|May 31, 2024
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry studyCamille Gondran, Pierre-Yves Dumas, Emilie Bérard, et al.
Pageof 1